Table 2.
Group | Number of patients | ||||
---|---|---|---|---|---|
All-cause death | Cardiac death | AMI | Revascularization | MACE | |
P-value | <0.001 | <0.001 | 0.433 | 0.308 | <0.001 |
Control | |||||
DM (n=20) | 2 | 1 | 1 | 0 | 3 |
NDM (n=69) | 9 | 1 | 0 | 0 | 9 |
Group 1 | |||||
DM (n=66) | 7 | 2 | 2 | 5 | 14 |
NDM (n=139) | 21 | 6 | 5 | 9 | 35 |
Group 2 | |||||
DM (n=83) | 33△## | 15## | 2 | 10 | 45△△## |
NDM (n=126) | 24§§ | 12 | 4 | 11 | 39§§ |
Group 3 | |||||
DM (n=73) | 43△△▽▽** | 31△△▽▽** | 0 | 5 | 48△△** |
NDM (n=142) | 68△△▽▽** | 46△△▽▽** | 0 | 11 | 79△△▽▽** |
△ P<0.05, △△ P<0.01, ACS vs. control group; # P<0.05, ## P<0.01, Group 2 vs. Group 1; * P<0.05, ** P<0.01, Group 3 vs. Group 1; ▽ P<0.05, ▽▽ P<0.01, Group 3 vs. Group 2; § P<0.05, §§ P<0.01, DM vs. NDM. ACS: acute coronary syndrome; AMI: acute myocardial infarction; DM: diabetes mellitus; NDM: non-diabetes mellitus; MACE: major cardiovascular events; UA: uric acid.